|
The Effect of Black Seeds (Nigella Sativa) on Prediabetic Overweight and Obese Adolescents
|
Ongoing
|
Nigella sativa seeds
|
3
|
2230500005
|
Family and Community Medicine Center (Dammam)
|
|
A Randomized, Double Blinded, Comparative Observational Interventional Study to Assess The Safety And Immunogenicity Of Hepatitis B Vaccine In Newborns / Adolescents And Adults Six Months Post Vaccination
|
Ongoing
|
EUVAX B VACCINE
|
4
|
HBV-001
|
King Fahad Medical City (Riyadh),General Medical Polyclinic (Jeddah) ,Dafa Special Polyclinic
|
|
Impact of using Zinc Oxide versus Moist Exposed Wound Ointment (MEBO) in treatment of second stage pressure ulcer: A randomized control clinical trial
|
Ongoing
|
MEBO and Zinc oxide topical
|
3
|
Version 5
|
King Abdullah Medical City (Makkah)
|
|
A Proof of Concept, Phase IIa, Open Label Study to Evaluate the Safety and Efficacy of Subcutaneous Implants of Afamelanotide in Patients with Xeroderma Pigmentosum (XP)
|
Ongoing
|
Afamelanotide
|
2a
|
CUV156
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A randomized, double-blind, double-dummy, parallel-group study, comparing the efficacy and safety of remibrutinib versus teriflunomide in participants with relapsing multiple sclerosis, followed by extended treatment with open-label remibrutinib
|
Ongoing
|
remibrutinib
|
3
|
CLOU064C123
|
King Faisal Specialist Hospital and Research Center (Jeddah) - King Abdulaziz Medical City NG (Jeddah) - King Abdulaziz Medical City NG (Riyadh)
|
|
An Open-label Extension Trial to Evaluate the Long-term Safety of KVD900, an Oral Plasma Kallikrein Inhibitor, for On-demand Treatment of Angioedema Attacks in Adolescent and Adult Patients with Hereditary Angioedema Type I or II
|
Ongoing
|
Sebetralstat
|
3
|
KVD900-302
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A prospective observational international study of cabozantinib tablets in combination with nivolumab as first-line treatment of advanced renal cell carcinoma in adults
|
Ongoing
|
Cabozantinib
|
4
|
CLIN-60000
|
King Abdulaziz Medical City NG (Riyadh)
|
|
A Phase 3, Randomized, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of Guselkumab in Participants with Fistulizing, Perianal Crohn’s Disease
|
Ongoing
|
Guselkumab
|
3
|
CNTO1959CRD3005
|
King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Specialist Hospital (Dammam), King Saud Medical City (Riyadh), King Abdulaziz Medical City NG (Jeddah)
|
|
A Randomized, Double-blind, Multicenter Study to Determine the Effect of Triheptanoin Compared with Even-chain, Medium-chain Triglycerides (MCT) on Major Clinical Events (MCEs) in Pediatric Patients with Long-chain Fatty Acid Oxidation Disorders (LC-FAOD)
|
Ongoing
|
UX007/triheptanoin, Medium-chain Triglycerides (MCT),Dextrose. Monosaccharide. Blood Glucose-Elevating Agents.
|
3
|
UX007-CL30
|
King Faisal Specialist Hospital and Research Center (Riyadh)
|
|
A non-interventional, multinational,observational study with isatuximabin patients with relapsed and/orrefractory multiple myeloma (RRMM)
|
Ongoing
|
SARCLISA® ( isatuximab - irfc )
|
4
|
OBS16577
|
Mouwasat Hospital (Dammam),King Faisal Specialist Hospital and Research Center (Jeddah),King Abdulaziz Medical City NG (Jeddah),King Abdulaziz Medical City NG (Riyadh)
|
